BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Update

Posted by George Bondi on Sep 28th, 2026

BlackRock Health Sciences Term Trust (NYSE:BMEZ – Get Free Report) saw a significant growth in short interest in September. As of September 15th, there was short interest totaling 83,940 shares, a growth of 178.9% from the August 31st total of 30,094 shares. Based on an average daily volume of 145,862 shares, the short-interest ratio is presently 0.6 days.

BlackRock Health Sciences Term Trust Stock Performance

BMEZ traded up $0.04 during midday trading on Monday, reaching $16.86. The company had a trading volume of 79,086 shares, compared to its average volume of 204,726. The business has a 50-day moving average of $16.29 and a two-hundred day moving average of $15.12. BlackRock Health Sciences Term Trust has a 1 year low of $13.70 and a 1 year high of $17.25.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, December 22nd. Investors of record on Friday, December 11th will be paid a dividend of $0.11 per share. The ex-dividend date is Friday, December 11th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 7.8%.

Institutional Investors Weigh In On BlackRock Health Sciences Term Trust

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Integrated Wealth Concepts LLC bought a new position in shares of BlackRock Health Sciences Term Trust in the second quarter worth approximately $46,000. Brown Lisle Cummings Inc. lifted its stake in shares of BlackRock Health Sciences Term Trust by 7.8% during the 2nd quarter. Brown Lisle Cummings Inc. now owns 57,026 shares of the company’s stock valued at $875,000 after buying an additional 4,108 shares in the last quarter. Corient Private Wealth LP bought a new position in BlackRock Health Sciences Term Trust in the 2nd quarter worth $467,000. Rivernorth Capital Management LLC increased its stake in BlackRock Health Sciences Term Trust by 24.8% in the 1st quarter. Rivernorth Capital Management LLC now owns 809,196 shares of the company’s stock worth $11,620,000 after buying an additional 160,629 shares in the last quarter. Finally, Saba Capital Management L.P. purchased a new stake in BlackRock Health Sciences Term Trust in the 1st quarter worth $10,907,000.

About BlackRock Health Sciences Term Trust

(Get Free Report)

BlackRock Health Sciences Term Trust (NYSE:BMEZ) is a publicly traded closed-end investment fund managed by BlackRock Advisors, LLC. The fund seeks to provide total returns through a combination of current income and long-term capital appreciation by investing primarily in companies involved in the health sciences sector.

BMEZ’s investment universe includes businesses in areas such as biotechnology, pharmaceuticals, medical devices, health-care services, and life-sciences tools and equipment.